Key findings from the Phase 2 trial included: Dose-dependent weight loss , with greater reductions observed at higher doses Significant improvements in waist circumference , blood pressure , and lipid profiles Reductions in fasting glucose and insulin resistance markers, though the clinical significance of these findings in people with type 2 diabetes requires further investigation Weight loss appeared to continue throughout the 48-week period without a clear plateau at the highest doses Whilst these results are encouraging, it is important to contextualise them appropriately
The brand's homepage displays a figure of 53,585+ patients (brand-stated, not independently audited)
We also weighed real-world feedback
Akkermansia muciniphila and microbial strains that produce butyrate such as Clostridium butyricum can augment GLP-1 production through natural stimulation of the L-cells
The range of indications for these drugs is broad and often debated
Cool-Down (2 Minutes) Gentle calf stretch, hamstring stretch, and deep breathing When to progress : after ~23 weeks of steady sessions with good form and no dizziness